IP Library › Granted Patent US 7,192,616
Granted Patent B2
US 7,192,616 · App. 10/258,806 · Granted Mar 20, 2007

Plant extract of the

Assignee: L'Oreal
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,192,616
App. No.
10/258,806
Granted
Mar 20, 2007
Kind
B2
Abstract

The invention concerns the use of an efficient amount of at least an extract of an least a plant of the Olea europaea species in a physiologically acceptable medium, in a composition or for preparing a composition, the extract or composition being designed to inhibit NO-synthase.

Claims (25)

1. A method for the treatment of erythema in a subject in need of such treatment, said method comprising topically administering to said subject a topical composition comprising an NO-synthase-inhibiting amount of an aqueous or alcoholic or aqueous-alcoholic extract or an organic solvent extract of at least one plant of the species Olea europaea effective to treat said erythema, in a topical physiologically acceptable medium.

2. The method according to claim 1 , wherein the extract is an aqueous propylene glycol extract.

3. The method according to claim 1 , wherein the erythema comprises localized erythematous eruptions of the skin.

4. The method according to claim 3 , wherein the erythematous eruptions are caused by at least one member selected from the group consisting of drugs, toxins, viral infections and bacterial infections.

5. The method according to claim 1 , wherein the erythema comprises diffuse erythematous eruptions of the skin.

6. The method according to claim 5 , wherein the erythematous eruptions are caused by at least one member selected from the group consisting of drugs, toxins, viral infections and bacterial infections.

7. The method according to claim 1 , wherein the extract is in an amount representing from 10 −4 % to 20% of the total weight of the composition.

8. The method according to claim 7 , wherein the extract is in an amount representing from 5×10 −3 % to 10% of the total weight of the composition.

9. The method according to claim 1 , wherein the extract is obtained from plant material derived from a whole plant or from leaves, from seeds or from roots, or from dedifferentiated cells.

10. The method according to claim 1 , wherein the extract is obtained from plant material derived from at least one plant cultured in vivo.

11. A method for the treatment of erythema induced by ultraviolet radiation in a subject in need of such treatment, said method comprising administering to said subject a composition comprising an NO-synthase-inhibiting amount of an aqueous or alcoholic or aqueous-alcoholic extract or an organic solvent extract of at least one plant of the species Olea europaea effective to treat said erythema, in a physiologically acceptable medium.

12. A method for the cosmetic treatment of erythema of the skin related to NO-synthesis, said method comprising apply an NO-synthase-inhibiting amount of an aqueous or-alcoholic or aqueous-alcoholic extract or an organic solvent extract of at least one plant of the species Olea europaea effective to treat said erythema, in a physiologically acceptable medium, to the skin and/or to the hair of a subject in need of such treatment.

13. The method according to claim 12 , wherein the extract is an aqueous propylene glycol extract.

14. A method for the treatment of erythema in a subject in need of such treatment, said method comprising topically administering to said subject a topical composition comprising an NO-synthase-inhibiting amount of an aqueous or alcoholic or aqueous-alcoholic extract or an organic solvent extract of Olea europaea leaves effective to treat said erythema, in a topical physiologically acceptable medium.

15. The method according to claim 14 , wherein the extract is an aqueous propylene glycol extract.

16. The method according to claim 14 , wherein the erythema comprises localized erythematous eruptions of the skin.

17. The method according to claim 16 , wherein the erythematous eruptions are caused by at least one member selected from the group consisting of drugs, toxins, viral infections and bacterial infections.

18. The method according to claim 14 , wherein the erythema comprises diffuse erythematous eruptions of the skin.

19. The method according to claim 18 , wherein the erythematous eruptions are caused by at least one member selected from the group consisting of drugs, toxins, viral infections and bacterial infections.

20. The method according to claim 14 , wherein the extract is a dry aqueous extract of Olea europaea leaves.

21. The method according to claim 14 , wherein the extract is in an amount representing from 10 −4 % to 20% of the total weight of the composition.

22. The method according to claim 21 , wherein the extract is in an amount representing from 5×10 −3 % to 10% of the total weight of the composition.

23. A method for the treatment of erythema induced by ultraviolet radiation in a subject in need of such treatment, said method comprising administering to said subject a composition comprising an NO-synthase-inhibiting amount of an aqueous or alcoholic or aqueous-alcoholic extract or an organic solvent extract of Olea europaea leaves effective to treat said erythema, in a physiologically acceptable medium.

24. A method for the cosmetic treatment of erythema of the skin related to NO-synthesis, said method comprising applying an NO-synthase-inhibiting amount of an aqueous or alcoholic or aqueous-alcoholic extract or an organic solvent extract of Olea europaea leaves effective to treat said erythema, in a physiologically acceptable medium, to the skin and/or to the hair of a subject in need of such treatment.

25. The method according to claim 24 , wherein the extract is an aqueous propylene glycol extract.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2003
From: CALS-GRIERSON, MARIE-MADELEINE; PELLETIER, PASCALE
To: L'OREAL
Reel/Frame 013784/0516 →
Priority Claims (1)
FR 00 05522 · Apr 28, 2000 · national
Continuity (1)
Related Publication 20030170331A1 · Sep 11, 2003